about
Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramineScreening of conventional anticonvulsants in a genetic mouse model of epilepsy.Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.The phenotypic spectrum of SCN8A encephalopathy.Tau reduction prevents disease in a mouse model of Dravet syndromeIn Silico Prediction of Gamma-Aminobutyric Acid Type-A Receptors Using Novel Machine-Learning-Based SVM and GBDT ApproachesOverall management of patients with Dravet syndrome."Electro-clinical syndromes" with onset in paediatric age: the highlights of the clinical-EEG, genetic and therapeutic advances.The promise of futility trials in neurological diseases.Palliative epilepsy surgery in Dravet syndrome-case series and review of the literature.The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.Purinergic control of hippocampal circuit hyperexcitability in Dravet syndrome.The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy.Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening.Heterozygous deletion of SCN2A and SCN3A in a patient with autism spectrum disorder and Tourette syndrome: a case report
P2860
Q27308068-E3DAC8B7-1BA1-47CE-AE4B-1FA3188510CCQ33646252-333F16B2-2457-4EE8-A8ED-471FF281C9D9Q34302354-95AE4543-B86E-40EC-B5AC-AAA940F349C4Q34530386-D618C732-EBCD-4A86-A9A2-F7ACC259A30EQ35106483-62504A3A-92A5-46FF-BDE6-DFAC5B20FA03Q35115219-24CED465-5743-4483-9637-DBBCF042F672Q36118214-036390F2-F4F6-4CCE-9CC2-D67A45843E4AQ37866833-E320AEFD-EA08-4FE0-BC46-6CA3CD2A00BCQ37969852-C14D4511-F700-4DFE-8D5B-594F9410D72EQ38380170-A7BCA896-F5E9-4EC1-BCFB-44C1A7A4B1D1Q38910600-E00C9F68-1D1B-40FE-B6CE-7275153672F8Q39136036-09F3DF7A-1C93-4726-BC40-62243B380B45Q42452341-9144263C-64C8-4D8D-A3FD-9FDB2E37AD04Q47111506-5BE06473-6336-48F2-80F6-790BAA189EFEQ51818804-7726B0B2-095E-445A-879B-B4F4339CE552Q55471525-56260EE3-B82A-4C8B-B10C-D7AA65861361Q58803177-6B4EDCAA-A9A0-45FB-A9BF-F2BA0978F9EA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current therapeutic procedures in Dravet syndrome.
@en
Current therapeutic procedures in Dravet syndrome.
@nl
type
label
Current therapeutic procedures in Dravet syndrome.
@en
Current therapeutic procedures in Dravet syndrome.
@nl
prefLabel
Current therapeutic procedures in Dravet syndrome.
@en
Current therapeutic procedures in Dravet syndrome.
@nl
P2860
P1476
Current therapeutic procedures in Dravet syndrome
@en
P2093
Catherine Chiron
P2860
P356
10.1111/J.1469-8749.2011.03967.X
P478
53 Suppl 2
P577
2011-04-01T00:00:00Z